2022 RESEARCH
- Archives -UMass Chan BRIDGE Fund supports seven faculty projects with commercialization potential
BRIDGE Innovation and Business Development at UMass Chan Medical School has awarded $2.2 million to seven faculty-led biomedical research projects.
Collaborative effort led by Marian Walhout spotlights worms as model for personalized medicine
UMass Chan researcher Marian Walhout, PhD, along with collaborators at Northwestern and Cornell, have developed an animal model system to interrogate individual differences in metabolism.
UMass Chan researchers study link between oral microbiome and long COVID
John P. Haran, MD, PhD, is studying neurological long-COVID symptoms in working-age, generally healthy people who were vaccinated prior to infection.
Making smoking cessation a game increases abstinence among smokers not yet ready to quit
A study co-authored by UMass Chan Medical School researchers showed that a technology-assisted abstinence game may help smokers kick the habit. Rajani Sadasivam was principal investigator on the study.
UMass Chan postdoc receives two fellowship awards to support brain research
Violeta Durán Laforet, PhD, has received two awards to study how cells in the brain affect aging. The information she learns could lead to Alzheimer’s disease treatments.
Communicating science: Elizabeth Shank works to identify new antibiotics by getting bacteria ‘talking’
In her lab, Elizabeth Shank, PhD, interprets the chemical language of bacteria with the goal of harnessing its power to potentially developing new antibiotics.
UMass Chan research explores differences in AAV vector manufacture, shows clear winner for method
A paper from the Horae Gene Therapy Center at UMass Chan Medical School may settle a longstanding debate about how to best manufacture adeno-associated virus vectors for gene therapy.
Just how accurate are rapid antigen tests? Two testing experts explain the latest data
In an article written for The Conversation, Nate Hafer, PhD, and Apurv Soni, MD, PhD'21, explain the data regarding accuracy of rapid COVID tests, based on their extensive reseach as part of the RADx team.
Study co-authored by UMass Chan researchers finds broad differences in SARS-CoV-2 infectiousness
Wide variation in the amount or infectiousness of SARS-CoV-2 among people in early stages of COVID-19 may be an explanation for the phenomenon of “super spreaders,” according to new research. Research co-author Laura Gibson, MD, talks about the findings.
MassBiologics research into preventive shot for Lyme disease continues to move forward
The human clinical trial into a preventive shot for Lyme disease, developed by MassBiologics at UMass Chan Medical School, continues to show promise, with Phase I expected to conclude this year and Phase II-III plans in development.